Eric Raymond
Treatment of advanced pancreatic islet cell tumors with sunitinib has doubled progression-free survival in patients whose options have been very limited up to now, according to French researchers reporting their phase III randomized study findings at the World Congress on Gastrointestinal Cancer in Barcelona (24-27 June, 2009; ABSTRACT: 0-0013). Eric Raymond from Beaujon University Hospital, Villejuif, France, gave Peter Goodwin his clinical interpretation of the findings.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
One Comment
I have been diagnosed with an islet cell neoplasm I am not hypoglycemic or diabetic have lost weight and i am not feeling very well I have lupus a pacemaker and antiphosoph0lipid i need to decide if the risk of removing the tumuor out whieghs leaving it untreated please help. best regards kathy